128 related articles for article (PubMed ID: 8911007)
1. An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep.
Kabeya H; Ohashi K; Ohishi K; Sugimoto C; Amanuma H; Onuma M
Vaccine; 1996 Aug; 14(12):1118-22. PubMed ID: 8911007
[TBL] [Abstract][Full Text] [Related]
2. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
3. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.
Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E
Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899
[TBL] [Abstract][Full Text] [Related]
4. T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development.
Gatei MH; Good MF; Daniel RC; Lavin MF
J Virol; 1993 Apr; 67(4):1796-802. PubMed ID: 7680386
[TBL] [Abstract][Full Text] [Related]
5. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.
Callebaut I; Vonèche V; Mager A; Fumière O; Krchnak V; Merza M; Zavada J; Mammerickx M; Burny A; Portetelle D
J Virol; 1993 Sep; 67(9):5321-7. PubMed ID: 7688821
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of tumor necrosis factor alpha mRNA is associated with bovine-leukemia virus (BLV) elimination in the early phase of infection.
Kabeya H; Ohashi K; Oyunbileg N; Nagaoka Y; Aida Y; Sugimoto C; Yokomizo Y; Onuma M
Vet Immunol Immunopathol; 1999 May; 68(2-4):255-65. PubMed ID: 10438324
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity.
Ohishi K; Suzuki H; Yamamoto T; Maruyama T; Miki K; Ikawa Y; Numakunai S; Okada K; Ohshima K; Sugimoto M
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1887-92. PubMed ID: 1651982
[TBL] [Abstract][Full Text] [Related]
8. Ovine MHC class II DRB1 alleles associated with resistance or susceptibility to development of bovine leukemia virus-induced ovine lymphoma.
Nagaoka Y; Kabeya H; Onuma M; Kasai N; Okada K; Aida Y
Cancer Res; 1999 Feb; 59(4):975-81. PubMed ID: 10029093
[TBL] [Abstract][Full Text] [Related]
9. Recombinant viral vaccines for enzootic bovine leucosis.
Daniel RC; Gatei MH; Good MF; Boyle DB; Lavin MF
Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():399-404. PubMed ID: 8270269
[TBL] [Abstract][Full Text] [Related]
10. Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes.
Cherney TM; Schultz RD
Am J Vet Res; 1996 Jun; 57(6):812-8. PubMed ID: 8725805
[TBL] [Abstract][Full Text] [Related]
11. Expression of the bovine leukemia virus envelope glycoprotein (gp51) by recombinant baculovirus and its use in an enzyme-linked immunosorbent assay.
De Giuseppe A; Feliziani F; Rutili D; De Mia GM
Clin Diagn Lab Immunol; 2004 Jan; 11(1):147-51. PubMed ID: 14715562
[TBL] [Abstract][Full Text] [Related]
12. The influence of ovine MHC class II DRB1 alleles on immune response in bovine leukemia virus infection.
Konnai S; Takeshima SN; Tajima S; Yin SA; Okada K; Onuma M; Aida Y
Microbiol Immunol; 2003; 47(3):223-32. PubMed ID: 12725293
[TBL] [Abstract][Full Text] [Related]
13. Peptide-based bovine leukemia virus (BLV) vaccine that induces BLV-Env specific Th-1 type immunity.
Ohishi K; Kabeya H; Amanuma H; Onuma M
Leukemia; 1997 Apr; 11 Suppl 3():223-6. PubMed ID: 9209348
[TBL] [Abstract][Full Text] [Related]
14. Elicitation of bovine antibody to BLV-gp51 by BLV-vaccination.
Maruyama K; Fukushima T; Mochizuki S; Abe H; Onuma M; Hasegawa A; Misawa M
Leukemia; 1988 Dec; 2(12 Suppl):216S-222S. PubMed ID: 2848999
[TBL] [Abstract][Full Text] [Related]
15. Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.
Ban J; Czene S; Altaner C; Callebaut I; Krchnak V; Merza M; Burny A; Kettmann R; Portetelle D
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2457-61. PubMed ID: 1383413
[TBL] [Abstract][Full Text] [Related]
16. gammadelta(+) T-Lp6phocyte cytotoxicity against envelope-expressing target cells is unique to the alymphocytic state of bovine leukemia virus infection in the natural host.
Lundberg P; Splitter GA
J Virol; 2000 Sep; 74(18):8299-306. PubMed ID: 10954528
[TBL] [Abstract][Full Text] [Related]
17. Protective vaccination against bovine leukaemia virus infection by means of cell-derived vaccine.
Altaner C; Ban J; Altanerova V; Janik V
Vaccine; 1991 Dec; 9(12):889-95. PubMed ID: 1667347
[TBL] [Abstract][Full Text] [Related]
18. Identification of an immunodominant region on the isolated bovine leukaemia virus (BLV) major envelope protein gp51 by monoclonal antibodies presumably not exposed during natural BLV infection.
Platzer C; Siakkou H; Sober J; Kopp J; Scheve E; Rosenthal S
Acta Virol; 1990 May; 34(3):246-55. PubMed ID: 1980398
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a recombinant vaccinia virus expressing envelope a glycoprotein of bovine leukaemia virus.
Ohishi K; Maruyama T; Shida H; Nishimaki J; Miki K; Sagata N; Ikawa Y; Sugimoto M
Vaccine; 1988 Oct; 6(5):428-32. PubMed ID: 2848378
[TBL] [Abstract][Full Text] [Related]
20. The bovine leukemia virus (BLV) envelope glycoprotein gp51 as a general model for the design of a subunit vaccine against retroviral infection: mapping of functional sites through immunological and structural data.
Callebaut I; Mornon JP; Burny A; Portetelle D
Leukemia; 1994 Apr; 8 Suppl 1():S218-21. PubMed ID: 7512181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
